These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 32087409)

  • 1. Using protein engineering to understand and modulate aggregation.
    Ebo JS; Guthertz N; Radford SE; Brockwell DJ
    Curr Opin Struct Biol; 2020 Feb; 60():157-166. PubMed ID: 32087409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AggreProt: a web server for predicting and engineering aggregation prone regions in proteins.
    Planas-Iglesias J; Borko S; Swiatkowski J; Elias M; Havlasek M; Salamon O; Grakova E; Kunka A; Martinovic T; Damborsky J; Martinovic J; Bednar D
    Nucleic Acids Res; 2024 Jul; 52(W1):W159-W169. PubMed ID: 38801076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of Protein Stability and Their Application in Computational Design.
    Goldenzweig A; Fleishman SJ
    Annu Rev Biochem; 2018 Jun; 87():105-129. PubMed ID: 29401000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubis: a webserver to reduce protein aggregation through mutation.
    Van Durme J; De Baets G; Van Der Kant R; Ramakers M; Ganesan A; Wilkinson H; Gallardo R; Rousseau F; Schymkowitz J
    Protein Eng Des Sel; 2016 Aug; 29(8):285-9. PubMed ID: 27284085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab.
    Courtois F; Agrawal NJ; Lauer TM; Trout BL
    MAbs; 2016; 8(1):99-112. PubMed ID: 26514585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGGRESCAN3D: Toward the Prediction of the Aggregation Propensities of Protein Structures.
    Pujols J; Peña-Díaz S; Ventura S
    Methods Mol Biol; 2018; 1762():427-443. PubMed ID: 29594784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remediating agitation-induced antibody aggregation by eradicating exposed hydrophobic motifs.
    Clark RH; Latypov RF; De Imus C; Carter J; Wilson Z; Manchulenko K; Brown ME; Ketchem RR
    MAbs; 2014; 6(6):1540-50. PubMed ID: 25484048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AggScore: Prediction of aggregation-prone regions in proteins based on the distribution of surface patches.
    Sankar K; Krystek SR; Carl SM; Day T; Maier JKX
    Proteins; 2018 Nov; 86(11):1147-1156. PubMed ID: 30168197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driving Forces for Nonnative Protein Aggregation and Approaches to Predict Aggregation-Prone Regions.
    Meric G; Robinson AS; Roberts CJ
    Annu Rev Chem Biomol Eng; 2017 Jun; 8():139-159. PubMed ID: 28592179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SolubiS: Optimizing Protein Solubility by Minimal Point Mutations.
    van der Kant R; van Durme J; Rousseau F; Schymkowitz J
    Methods Mol Biol; 2019; 1873():317-333. PubMed ID: 30341620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of protein aggregation.
    Khalili K; Farzam F; Dabirmanesh B; Khajeh K
    Prog Mol Biol Transl Sci; 2024; 206():229-263. PubMed ID: 38811082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A3D 2.0 Update for the Prediction and Optimization of Protein Solubility.
    Pujols J; Iglesias V; Santos J; Kuriata A; Kmiecik S; Ventura S
    Methods Mol Biol; 2022; 2406():65-84. PubMed ID: 35089550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic protein aggregation: mechanisms, design, and control.
    Roberts CJ
    Trends Biotechnol; 2014 Jul; 32(7):372-80. PubMed ID: 24908382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational Design To Reduce Conformational Flexibility and Aggregation Rates of an Antibody Fab Fragment.
    Zhang C; Samad M; Yu H; Chakroun N; Hilton D; Dalby PA
    Mol Pharm; 2018 Aug; 15(8):3079-3092. PubMed ID: 29897777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Prediction of Protein Aggregation Propensity.
    Pallarés I; Ventura S
    Curr Med Chem; 2019; 26(21):3911-3920. PubMed ID: 28685682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrostatic interactions modulate the differential aggregation propensities of IgG1 and IgG4P antibodies and inform charged residue substitutions for improved developability.
    Heads JT; Lamb R; Kelm S; Adams R; Elliott P; Tyson K; Topia S; West S; Nan R; Turner A; Lawson ADG
    Protein Eng Des Sel; 2019 Dec; 32(6):277-288. PubMed ID: 31868219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered antibody CH2 domains binding to nucleolin: Isolation, characterization and improvement of aggregation.
    Li D; Gong R; Zheng J; Chen X; Dimitrov DS; Zhao Q
    Biochem Biophys Res Commun; 2017 Apr; 485(2):446-453. PubMed ID: 28202413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational methods to predict protein aggregation.
    Navarro S; Ventura S
    Curr Opin Struct Biol; 2022 Apr; 73():102343. PubMed ID: 35240456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANuPP: A Versatile Tool to Predict Aggregation Nucleating Regions in Peptides and Proteins.
    Prabakaran R; Rawat P; Kumar S; Michael Gromiha M
    J Mol Biol; 2021 May; 433(11):166707. PubMed ID: 33972019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational re-design of protein structures to improve solubility.
    Navarro S; Ventura S
    Expert Opin Drug Discov; 2019 Oct; 14(10):1077-1088. PubMed ID: 31282222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.